Precision AQ
Jeroen P. Jansen, PhDExecutive Vice President, Chief Scientist
Leading methodologist working at the intersection of statistics, evidence synthesis, and health economics. He has over 20 years of research experience to understand the clinical and economic value of novel health technologies, supporting drug development, market access decisions, and health technology assessment. His work has been highly cited and established him as a thought leader in HEOR.
Insights from Jeroen P. Jansen, PhD
Commercialization & Access | Presentation
Can Distributional Cost Effectiveness Analysis Actually Inform On and Improve Health Equity in Oncology?